biospecimen__admin__batch_number	231.65.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	C51C24D8-ED6F-4D09-8075-70B24F93C396
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-FV-A3I0-11A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-FV-A3I0-11A-11
biospecimen__bio__bcr_sample_barcode	TCGA-FV-A3I0-11A
biospecimen__bio__biospecimen_barcode_bottom	0118955560
biospecimen__bio__day_of_creation	01
biospecimen__bio__day_of_shipment	30
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	02
biospecimen__bio__month_of_shipment	05
biospecimen__bio__plate_column	8
biospecimen__bio__plate_id	A22L
biospecimen__bio__plate_row	E
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	2.21
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	13.00
biospecimen__bio__year_of_creation	2012
biospecimen__bio__year_of_shipment	2012
biospecimen__shared__bcr_patient_barcode	TCGA-FV-A3I0
biospecimen__shared__patient_id	A3I0
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	B035D1CD-2E10-47C0-A04D-B374A4162723
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_specified_value	4.40
clinical__chol_lihc_shared__bilirubin_upper_limit	0.4
clinical__chol_lihc_shared__hist_hepato_carc_fact	No History of Primary Risk Factors
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__vascular_tumor_cell_type	Micro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	76
clinical__clin_shared__bcr_followup_barcode	TCGA-FV-A3I0-F57854
clinical__clin_shared__bcr_followup_uuid	D8CBBFD6-88E3-477D-914A-7CF67093DC68
clinical__clin_shared__day_of_form_completion	27
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__measure_of_response	Clinical Progressive Disease
clinical__clin_shared__month_of_form_completion	4
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2011
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	Yes
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	YES
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	159
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Intrahepatic Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__rx__bcr_drug_barcode	TCGA-FV-A3I0-D57855
clinical__rx__bcr_drug_uuid	CE83DB6D-029E-4406-84CE-771A43CC490D
clinical__rx__days_to_drug_therapy_end	586
clinical__rx__days_to_drug_therapy_start	166
clinical__rx__drug_name	Gemcitabine
clinical__rx__therapy_ongoing	NO
clinical__rx__therapy_type	Chemotherapy
clinical__rx__tx_on_clinical_trial	NO
clinical__shared__histological_type	Hepatocholangiocarcinoma (Mixed)
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	NX
clinical__shared_stage__pathologic_t	T2
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	07401514-29ef-43a8-8a7f-a4e147852470
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-FV-A3I0-11A-11R-A22L-07
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	c55df4b9-195d-4026-a87e-238ef88b11b3,04bf6f7d-29aa-4eb5-9643-4579a28e3ffd,faa8f30a-af1d-437e-b6d8-02b4c6191cc0
gdc__analysis__workflow_link	https://github.com/NCI-GDC/htseq-cwl
gdc__analysis__workflow_type	HTSeq - FPKM,HTSeq - Counts,HTSeq - FPKM-UQ
gdc__analysis__workflow_version	v1
gdc__analytes__a260_a280_ratio	1.83
gdc__analytes__analyte_id	4afc6bfe-bb8e-4ab2-b2ab-7175da37f7f1
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	a8c2aa08-9156-4845-ad77-5e060858c757
gdc__center__center_id	ee7a85b3-8177-5d60-a10c-51180eb9009c
gdc__center__center_type	CGCC
gdc__center__code	07
gdc__center__name	University of North Carolina
gdc__center__namespace	unc.edu
gdc__center__short_name	UNC
gdc__created_datetime	2016-05-30T18:38:46.141508-05:00,2016-05-30T18:38:45.738551-05:00,2016-05-30T18:38:45.963537-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	Gene Expression Quantification
gdc__demographic__demographic_id	690e2dd1-aa31-54af-b56f-39feacaa7ecf
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	white
gdc__demographic__year_of_birth	1935
gdc__diagnoses__age_at_diagnosis	28101
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-28101.0
gdc__diagnoses__days_to_last_follow_up	848.0
gdc__diagnoses__diagnosis_id	8b63bf23-2c22-5ee5-89b4-0be69c1ea61a
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8180/3
gdc__diagnoses__primary_diagnosis	Combined hepatocellular carcinoma and cholangiocarcinoma
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage ii
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	RNA-Seq
gdc__exposures__exposure_id	3991f016-a7e3-5060-bdd5-d42d5965641a
gdc__file_id	0cdc9d01-3f5f-4cc1-aa74-b14082c0f446,96daf97d-3b90-4dd9-9cf9-6b3c3a9f3a06,f29dd092-a451-461a-bdbf-b6a1cf23e440
gdc__file_name	d0000779-67f0-46d6-9e09-546f32a80700.FPKM.txt.gz,d0000779-67f0-46d6-9e09-546f32a80700.htseq.counts.gz,d0000779-67f0-46d6-9e09-546f32a80700.FPKM-UQ.txt.gz
gdc__file_size	463410,240080,464746
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	RNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	1fa932ae7de6ab6d7b7142fb060d206a,e1a55a253e31633b68b483b1370d8e41,818dcb77a6b44f1193a800a5e64e2926
gdc__portions__is_ffpe	false
gdc__portions__portion_id	a5521e26-4c6b-46da-b28e-ac49e176fc6b
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	70
gdc__samples__initial_weight	40.0
gdc__samples__oct_embedded	false
gdc__samples__sample_id	52bca35c-ecf3-4e3c-8e98-596622b4adfd
gdc__samples__sample_type	Solid Tissue Normal
gdc__samples__sample_type_id	11
gdc__slides__percent_lymphocyte_infiltration	1.0
gdc__slides__percent_monocyte_infiltration	1.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	1.0
gdc__slides__percent_normal_cells	90.0
gdc__slides__percent_stromal_cells	10.0
gdc__slides__percent_tumor_cells	0.0
gdc__slides__percent_tumor_nuclei	0.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	15941d99-f55b-494a-a730-da7d68792680
gdc__submitter_id	d0000779-67f0-46d6-9e09-546f32a80700_fpkm,d0000779-67f0-46d6-9e09-546f32a80700_count,d0000779-67f0-46d6-9e09-546f32a80700_uqfpkm
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	FV
gdc__tissue_source_site__name	International Genomics Consortium
gdc__tissue_source_site__tissue_source_site_id	98428b7d-30e7-5283-b22d-450c17717d09
gdc__treatments__treatment_id	9b33ca58-cb03-5830-befe-59d6294d30e2
gdc__type	gene_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T08:04:52.779+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/07401514-29ef-43a8-8a7f-a4e147852470-geq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/07401514-29ef-43a8-8a7f-a4e147852470-geq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	4970175
manually_curated__local_md5	5871b6ef7e43c00cc1bff28675696061
manually_curated__opengdc_download_date	2018-10-15T16:30:16.000531+02:00
manually_curated__opengdc_file_md5	47da192dd0a8ce1ba9ab8c9591da3c9f
manually_curated__opengdc_file_size	1583704
manually_curated__opengdc_id	07401514-29ef-43a8-8a7f-a4e147852470-geq
manually_curated__origin_file_size	4970175
manually_curated__origin_last_modified_date	Mon Oct 15 16:36:00 CEST 2018
manually_curated__origin_md5	5871b6ef7e43c00cc1bff28675696061
manually_curated__tissue_status	normal
num	60483
